Suchergebnisse - "Collery, Philippe"

PubPharm (41)

1

Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast Cancer Chicken Embryo Model

enthalten in: Anticancer research | 2024

von Collery, P. | Prunier, C. | Dosda, E. | +4

2

Plasma Rhenium and Selenium Concentrations After Repeated Daily Oral Administration of Rhenium(I)-diselenoether in 4T1 Breast Tumor-bearing Mice

enthalten in: Anticancer research | 2023

von Collery, P. | Michalke, B. | Lucio, M. | +5

3

Remarkable Effects of a Rhenium(I)-diselenoether Drug on the Production of Cathepsins B and S by Macrophages and their Polarizations

enthalten in: Current pharmaceutical design | 2023

von Collery, P. | Desmaële, D. | Harikrishnan, A. | +1

4

Quantification of drug loading in polymeric nanoparticles using AFM-IR technique : a novel method to map and evaluate drug distribution in drug nanocarriers

enthalten in: The Analyst | 2022

von Ural, M. | Dartois, E. | Mathurin, J. | +5

5

Relationship between the oxidative status and the tumor growth in transplanted triple-negative 4T1 breast tumor mice after oral administration of rhenium(I)-diselenoether

enthalten in: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) | 2022

von Collery, P. | Lagadec, P. | Krossa, I. | +8

6

Effects of Rhenium(I)-diselenoether and of its Diselenide Ligand on the Production of Cathepsins B and S by MDA-MB231 Breast Malignant Cells

enthalten in: Anticancer research | 2021

von Collery, P. | Veena, V. | Desmaële, D. | +2

7

A New Model Applied for Evaluating a Rhenium-diselenium Drug : Breast Cancer Cells Stimulated by Cytokines Induced from Polynuclear Cells by LPS

enthalten in: Anticancer research | 2020

von Veena, V. | Harikrishnan, A. | Lakshmi, B. | +3

8

The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers

enthalten in: Investigational new drugs | 2019

von Collery, P. | Veena, V. | Harikrishnan, A. | +1

9

The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers

enthalten in: Investigational new drugs | 2019

von Collery, P. | Veena, V. | Harikrishnan, A. | +1

10

The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers

enthalten in: Investigational new drugs | 2019

von Collery, P. | Veena, V. | Harikrishnan, A. | +1

1
2
3
4
5
Nächster »
[5]